Renhe Pharmacy Co Ltd
Renhe Pharmacy Co.,Ltd produces and sells pharmaceutical products. It offers Chinese and western medicines and raw materials; and health-related products, including oral solid preparations and liquid preparations, large-volume and small-volume injections, external lotions, liniments, suppositories, ointments, and other dosage forms of drugs and health-related products. The company was founded in … Read more
Renhe Pharmacy Co Ltd (000650) - Total Liabilities
Latest total liabilities as of September 2025: CN¥1.06 Billion CNY
Based on the latest financial reports, Renhe Pharmacy Co Ltd (000650) has total liabilities worth CN¥1.06 Billion CNY as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Renhe Pharmacy Co Ltd - Total Liabilities Trend (1993–2024)
This chart illustrates how Renhe Pharmacy Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Renhe Pharmacy Co Ltd Competitors by Total Liabilities
The table below lists competitors of Renhe Pharmacy Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Qurient Co. Ltd
KQ:115180
|
Korea | ₩6.81 Billion |
|
PATTIES FOODS - Frankfurt Stock Exchang
F:PH4
|
Germany | €876.86 Million |
|
Nano Nuclear Energy Inc. Common Stock
NASDAQ:NNE
|
USA | $6.09 Million |
|
CT Real Estate Investment Trust
PINK:CTRRF
|
USA | $3.27 Billion |
|
IntegraFin Holdings plc
PINK:IHPGF
|
USA | $33.85 Billion |
|
SpartanNash Company
F:SRJ
|
Germany | €1.82 Billion |
|
Sensirion Holding AG
SW:SENS
|
Switzerland | CHF67.30 Million |
|
Workspace Group plc
PINK:WKPPF
|
USA | $955.40 Million |
Liability Composition Analysis (1993–2024)
This chart breaks down Renhe Pharmacy Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 5.10 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.17 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.13 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Renhe Pharmacy Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Renhe Pharmacy Co Ltd (1993–2024)
The table below shows the annual total liabilities of Renhe Pharmacy Co Ltd from 1993 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥676.48 Million | -14.39% |
| 2023-12-31 | CN¥790.18 Million | -34.69% |
| 2022-12-31 | CN¥1.21 Billion | +23.33% |
| 2021-12-31 | CN¥981.00 Million | +41.25% |
| 2020-12-31 | CN¥694.54 Million | +9.81% |
| 2019-12-31 | CN¥632.47 Million | -9.86% |
| 2018-12-31 | CN¥701.67 Million | +0.97% |
| 2017-12-31 | CN¥694.95 Million | +5.23% |
| 2016-12-31 | CN¥660.41 Million | +18.91% |
| 2015-12-31 | CN¥555.41 Million | +27.66% |
| 2014-12-31 | CN¥435.06 Million | +11.59% |
| 2013-12-31 | CN¥389.86 Million | +1.85% |
| 2012-12-31 | CN¥382.80 Million | -16.91% |
| 2011-12-31 | CN¥460.68 Million | -18.63% |
| 2010-12-31 | CN¥566.13 Million | +177.90% |
| 2009-12-31 | CN¥203.72 Million | +54.10% |
| 2008-12-31 | CN¥132.20 Million | +80.99% |
| 2007-12-31 | CN¥73.04 Million | -5.16% |
| 2006-12-31 | CN¥77.01 Million | -81.18% |
| 2005-12-31 | CN¥409.12 Million | -5.23% |
| 2004-12-31 | CN¥431.68 Million | -2.16% |
| 2003-12-31 | CN¥441.21 Million | +4.82% |
| 2002-12-31 | CN¥420.93 Million | +10.67% |
| 2001-12-31 | CN¥380.36 Million | +24.18% |
| 2000-12-31 | CN¥306.29 Million | +42.64% |
| 1999-12-31 | CN¥214.72 Million | +70.01% |
| 1998-12-31 | CN¥126.30 Million | +6.35% |
| 1997-12-31 | CN¥118.76 Million | -6.25% |
| 1996-12-31 | CN¥126.67 Million | +5.97% |
| 1995-12-31 | CN¥119.54 Million | -3.67% |
| 1994-12-31 | CN¥124.08 Million | +6.29% |
| 1993-12-31 | CN¥116.74 Million | -- |